Pfizer/Takeda Launch One-Click Pen Enbrel Injection For Rheumatoid Arthritis In Japan
This article was originally published in PharmAsia News
Executive Summary
Pfizer and Takeda Pharmaceuticals announced June 10 they have launched the rheumatoid arthritis drug Enbrel (etanercept) as a new pen-type injection.